Skip to main content
SpringerLink
Log in

Ist Carvedilol anderen β-Blockern in der Vermeidung inadäquater ICD-Interventionen überlegen?

Is carvedilol superior to other beta blockers in preventing inadequate ICD interventions?

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rees JB van,Orleffs CJ, Bie MK de et al (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57:556–562

    Article  PubMed  Google Scholar 

  2. Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338

    Article  PubMed  Google Scholar 

  4. Daubert JP, Zareba W, Cannom DS et al (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51:1357–1365

    Article  PubMed  Google Scholar 

  5. Moss AJ, Schuger C, Beck CA et al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283

    Article  CAS  PubMed  Google Scholar 

  6. Raitt MH (2013) Inappropriate implantable defibrillator shocks: an adverse outcome that can be prevented. J Am Coll Cardiol 62:1351–1352

    Article  PubMed  Google Scholar 

  7. Ruwald MH, Abu-Zeitone A, Jons C et al (2013) Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol 62:1343–1350

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Herzverbund Südniedersachsen, Helios Albert-Schweitzer-Klinik, Sturmbäume 8, 37154, Northeim, Deutschland

    C. Özcelik

Authors
  1. C. Özcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özcelik, C. Ist Carvedilol anderen β-Blockern in der Vermeidung inadäquater ICD-Interventionen überlegen?. Kardiologe 8, 7–8 (2014). https://doi.org/10.1007/s12181-013-0544-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-013-0544-x

Search

Navigation